ArticleJournal of enzyme inhibition and medicinal chemistry2025

Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer.

Yingxiang Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.